Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127631361 | 12763136 | 1 | I | 20090410 | 20160908 | 20160920 | 20160920 | EXP | US-AMNEAL PHARMACEUTICALS-2016AMN00577 | AMNEAL | 69.00 | YR | F | Y | 88.44000 | KG | 20160920 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127631361 | 12763136 | 1 | PS | NAPROXEN. | NAPROXEN | 1 | UNK | Y | 75927 | ||||||||||
| 127631361 | 12763136 | 2 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | 0 | |||||||||||
| 127631361 | 12763136 | 3 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | UNK | 0 | |||||||||||
| 127631361 | 12763136 | 4 | C | DIOVAN | VALSARTAN | 1 | UNK | 0 | |||||||||||
| 127631361 | 12763136 | 5 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 127631361 | 12763136 | 6 | C | NEURONTIN | GABAPENTIN | 1 | UNK | 0 | |||||||||||
| 127631361 | 12763136 | 7 | C | LISINOPRIL. | LISINOPRIL | 1 | UNK | 0 | |||||||||||
| 127631361 | 12763136 | 8 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | UNK | 0 | |||||||||||
| 127631361 | 12763136 | 9 | C | DYAZIDE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | UNK | 0 | |||||||||||
| 127631361 | 12763136 | 10 | C | DIGOXIN. | DIGOXIN | 1 | 0 | ||||||||||||
| 127631361 | 12763136 | 11 | C | calcium with vitamin D | CALCIUMVITAMIN D | 1 | UNK | 0 | |||||||||||
| 127631361 | 12763136 | 12 | C | vitmain B12 | 2 | UNK | 0 | ||||||||||||
| 127631361 | 12763136 | 13 | C | VITAMIN B6 | PYRIDOXINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 127631361 | 12763136 | 14 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
| 127631361 | 12763136 | 15 | C | magnessium | 2 | UNK | 0 | ||||||||||||
| 127631361 | 12763136 | 16 | C | iron | IRON | 1 | UNK | 0 | |||||||||||
| 127631361 | 12763136 | 17 | C | vitmain D | 2 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127631361 | 12763136 | 1 | Osteoarthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127631361 | 12763136 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127631361 | 12763136 | Atrial fibrillation | |
| 127631361 | 12763136 | Coronary artery disease | |
| 127631361 | 12763136 | Non-cardiac chest pain | |
| 127631361 | 12763136 | Pulmonary congestion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127631361 | 12763136 | 1 | 20070227 | 20090817 | 0 | |
| 127631361 | 12763136 | 2 | 20070226 | 0 | ||
| 127631361 | 12763136 | 3 | 200908 | 0 | ||
| 127631361 | 12763136 | 4 | 2007 | 0 | ||
| 127631361 | 12763136 | 5 | 200201 | 0 | ||
| 127631361 | 12763136 | 6 | 200908 | 0 | ||
| 127631361 | 12763136 | 7 | 2003 | 0 | ||
| 127631361 | 12763136 | 8 | 20090517 | 0 | ||
| 127631361 | 12763136 | 9 | 200601 | 0 | ||
| 127631361 | 12763136 | 11 | 2000 | 0 | ||
| 127631361 | 12763136 | 12 | 1995 | 0 | ||
| 127631361 | 12763136 | 13 | 1995 | 0 | ||
| 127631361 | 12763136 | 14 | 1995 | 0 | ||
| 127631361 | 12763136 | 15 | 1995 | 0 | ||
| 127631361 | 12763136 | 16 | 200707 | 0 | ||
| 127631361 | 12763136 | 17 | 20080301 | 0 |